• Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival 

      Stensvold, Einar; Myklebust, Tor Åge; Cappelen, Johan; Due-Tønnessen, Bernt Johan; Due-Tønnessen, Paulina; Kepka, Aleksandra; Johannessen, Tom Børge; Krossnes, Bård Kronen; Lundar, Tryggve; Maric, Snezana; Miletic, Hrvoje; Moholdt, Viggo; Myrmel, Kristin Smistad; Nordberg, Terje; Rydland, Jana; Stokland, Tore; Solem, Kristin; Solheim, Ole; Torsvik, Ingrid Kristin; Wikran, Gry Charlotte; Zeller, Bernward; Wesenberg, Finn; Bechensteen, Anne Grete; Brandal, Petter (Peer reviewed; Journal article, 2019)
      Background: A previous study based on Norwegian Cancer Registry data suggested regional differences in overall survival (OS) after treatment for medulloblastoma (MB) and supratentorial primitive neuroectodermal tumor ...
    • Glioblastom hos voksne 

      Schipmann, Stephanie; Sivakanesan, Sarankan; Rath, Daniel Stavne; Brandal, Petter; Vik-Mo, Einar Osland; Bjørås, Magnar; Solheim, Ole Skeidsvoll; Ingebrigtsen, Tor; Sund, Fredrik; Bjerkvig, Rolf; Miletic, Hrvoje; Johannessen, Tor-Christian Aase; Sundstrøm, Terje (Peer reviewed; Journal article, 2023)
      lioblastom er den vanligste formen for primær hjernekreft hos voksne, og sykdommen har en alvorlig prognose. Selv om det er gjort store fremskritt i molekylær karakteristikk, har det ikke vært større gjennombrudd i ...
    • Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden 

      Heggebø, Liv Cathrine; Borgen, Ida Maria Henriksen; Rylander, Hillevi; Kiserud, Cecilie E.; Nordenmark, Tonje Kristin Haug; Hellebust, Taran Annette Paulsen; Evensen, Morten Egeberg; Gustavsson, Magnus; Ramberg, Christina; Sprauten, Mette; Magelssen, Henriette; Blakstad, Hanne; Moorthy, Janani; Andersson, Karin; Raunert, Ingela; Henry, Thomas; Moe, Cecilie; Granlund, Carin; Goplen, Dorota; Brekke, Jorunn; Johannessen, Tor-Christian Aase; Solheim, Tora S; Marienhagen, Kirsten; Humberset, Øyvind; Bergström, Per; Agrup, Måns; Dahl, Ludvig; Gubanski, Michael; Gojon, Helene; Brahme, Carl-Johan; Rydén, Isabelle; Jakola, Asgeir Store; Vik-Mo, Einar O.; Lie, Hanne Cathrine; Asphaug, Lars; Hervani, Maziar; Kristensen, Ingrid; Rüegg, Corina Silvia; Olsen, Inge Christoffer; Ledal, Rolf J; Degsell, Eskil; Werlenius, Katja; Blomstrand, Malin; Brandal, Petter (Peer reviewed; Journal article, 2023)
      Abstract Introduction The use of proton therapy increases globally despite a lack of randomised controlled trials demonstrating its efficacy and safety. Proton therapy enables sparing of non-neoplastic tissue from ...
    • Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy 

      Stokkevåg, Camilla Hanquist; Indelicato, Daniel J.; Herfarth, Klaus; Magelssen, Henriette; Evensen, Morten Egeberg; Ugland, Maren; Nordberg, Terje; Nystad, Tove Anita; Hægeland, Camilla; Alsaker, Mirjam Delange; Ulven, Kjetil; Dale, Jon Espen; Engeseth, Grete May; Boer, Camilla G.; Toussaint, Laura; Kornerup, Josefine Frida Margareta Ståhl; Pettersen, Helge Egil Seime; Brydøy, Marianne; Brandal, Petter; Muren, Ludvig Paul (Peer reviewed; Journal article, 2019)
      Background: Children with brain tumors undergoing radiotherapy are at particular risk of radiation-induced morbidity and are therefore routinely considered for proton therapy (PT) to reduce the dose to healthy tissues. The ...
    • Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study 

      Skaga, Erlend; Trewin-Nybråten, Cassia Bree; Niehusmann, Pitt; Johannessen, Tom Børge; Marienhagen, Kirsten; Oltedal, Leif; Schipmann, Stephanie; Skjulsvik, Anne Jarstein; Solheim, Ole Skeidsvoll; Solheim, Tora S; Sundstrøm, Terje; Vik-Mo, Einar Osland; Brandal, Petter; Ingebrigtsen, Tor (Journal article; Peer reviewed, 2024)
      Background: Surveillance of incidence and survival of central nervous system tumors is essential to monitor disease burden and epidemiological changes, and to allocate health care resources. Here, we describe glioma incidence ...